Y. Hok‐A‐Hin

Apolipoprotein L1 is increased in frontotemporal lobar degeneration post-mortem brain but not in ante-mortem cerebrospinal fluid

C. Teunissen, J. Swieten, J. Hoozemans, 2022, Neurobiology of Disease.

Guidelines for CSF Processing and Biobanking: Impact on the Identification and Development of Optimal CSF Protein Biomarkers.

C. Teunissen, E. Willemse, Yanaika S. Hok‐A‐Hin, 2019, Methods in molecular biology.

A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias

L. Parnetti, E. Vanmechelen, C. Teunissen, 2022, Journal of Alzheimer's disease : JAD.

CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels

W. M. van der Flier, A. Levey, N. Seyfried, 2022, Nature Aging.

YKL-40 changes are not detected in post-mortem brain of patients with Alzheimer’s disease and frontotemporal lobar degeneration

W. M. van der Flier, Y. Pijnenburg, C. Teunissen, 2022, Alzheimer's research & therapy.

CSF proteome profiling reveals highly specific biomarkers for dementia with Lewy bodies.

J. David, S. Engelborghs, A. Lleó, 2023, medRxiv.